Clinical Trials
3
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors
- First Posted Date
- 2017-05-10
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- NantPharma, LLC
- Registration Number
- NCT03147976
- Locations
- 🇺🇸
Chan Soon-Shiong Institute for Medicine, El Segundo, California, United States
QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma
- First Posted Date
- 2017-04-27
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- NantPharma, LLC
- Target Recruit Count
- 8
- Registration Number
- NCT03132155
- Locations
- 🇺🇸
Chan Soon-Shiong Institute for Medicine, El Segundo, California, United States
🇺🇸The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States
QUILT-2.022 NANT-008 in Combination w/ 5-fluorouracil, Bevacizumab, Leucovorin & Oxaliplatin in Subjects With Pancreatic Cancer
Phase 1
Withdrawn
- Conditions
- Pancreatic Adenocarcinoma Metastatic
- Interventions
- Drug: Eloxatin Injectable Product
- First Posted Date
- 2017-04-25
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- NantPharma, LLC
- Registration Number
- NCT03127124
- Locations
- 🇺🇸
Chan Soon-Shiong Institutes for Medicine, El Segundo, California, United States
News
No news found